A phase 3 study shows tafasitamab combined with lenalidomide and R-CHOP significantly improves outcomes for untreated DLBCL patients.
The researchers in a recent breakthrough have discovered a revolutionary cancer treatment in which healthy cells would be largely unharmed. Scientists belonging to RMIT University have ...
Aged and frail people often suffer a decline in tissue reserve capacity during aging. This reserve, called resilience, helps ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback